SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-032468
Filing Date
2024-02-12
Accepted
2024-02-12 19:51:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d763510dsc13ga.htm SC 13G/A 36697
  Complete submission text file 0001193125-24-032468.txt   37997
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Subject) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80200 | Film No.: 24622142
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address
BELANOFF JOSEPH K (Filed by) CIK: 0001286199 (see all company filings)

Type: SC 13G/A